PR Newswire | Jan 4, 2022 05:01PM EST

01/04 16:00 CST

Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference DUBLIN, Jan. 4, 2022

DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 a.m. EST.

A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo International plc

Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate team members collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.

View original content: https://www.prnewswire.com/news-releases/endo-to-participate-at-jp-morgan-40th-annual-healthcare-conference-301453716.html

SOURCE Endo International plc